Our overall aim was to contribute mechanistic specificity to the task of selecting patients most likely to benefit from GLP-1 agonist therapy
After incubation at room temperature for 1.5 h, the membranes were solubilized by the addition of 0.5% (w/v) Lauryl Maltose Neopentylglycol (LMNG, Anatrace) and 0.1% (w/v) Cholesteryl Hemisuccinate TRIS salt (CHS, Anatrace) for 2 h at 4 C
Prices for GLP-1 weight-loss medications are dropping fast
The plates were briefly stirred and activity was spectrophotometrically determined (SpectraMax ABS Plus, Molecular Devices) at room temperature in kinetic mode at the specific wavelength for each substrate (described above)
For most people: YES The math: 58.6% achieved 25% weight loss in TRIUMPH-4 (surgical-level outcomes) 81.8% tolerated medication and continued in TRIUMPH-4
[DOI] [PubMed] [Google Scholar] 141.Mokhtari, V., Afsharian, P., Shahhoseini, M., Kalantar, S